Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 10, 2025

Primary Completion Date

October 10, 2025

Study Completion Date

December 10, 2025

Conditions
Critical Illness
Interventions
DRUG

Vasopressin

"To dilute vasopressin, an ampoule containing 20 IU/ml (1 ml) of vasopressin will be used, which will be mixed with 100 ml of 0.9% physiological solution, resulting in a solution with a concentration of 0.2 IU/ ml. In this study, both central and peripheral vein infusion will be permitted.~The vasopressin administration protocol will consist of an initial dose of 0.02 IU/min (equivalent to 6 ml/h), which can be increased to 0.03 IU/min (9 ml/h) if the mean arterial pressure (MAP) is less than or equal to 65 mmHg. On the other hand, if MAP exceeds 90 mmHg, the dose can be reduced to 0.01 IU/min (3 ml/h). The minimum period for adjusting the drug dosage should be one hour."

OTHER

0,9% saline solution

Similar to the intervention protocol, but using a placebo composed of 0.9% saline solution.

Trial Locations (1)

03115-001

RECRUITING

Matheus Liguori Feliciano da Silva, São Paulo

All Listed Sponsors
lead

Hospital do Coracao

OTHER